Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fujifilm Toyama Chemical is a Japanese pharmaceutical company that specializes in the research, development, and manufacturing of innovative diagnostic and therapeutic agents. Formed through the 2018 merger of Toyama Chemical and Fujifilm Pharma, the company operates as a core subsidiary of Fujifilm Holdings Corporation. It is globally recognized for developing the antiviral drug Avigan (favipiravir), which is used for influenza and has been extensively studied for its efficacy against COVID-19. The company leverages Fujifilm's advanced imaging technologies to develop a robust pipeline of radiopharmaceuticals and liposomal drug delivery systems. Its primary therapeutic focus areas include infectious diseases, central nervous system disorders, and oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toyama Chemicals.